Recently Patented Viral Nucleotide Sequences and Generation of Virus-Derived Vaccines

Recent Pat Antiinfect Drug Discov. 2017;12(1):31-43. doi: 10.2174/1574891X12666170619102506.

Abstract

Background: With an increase in comprehension of the molecular biology of viruses, there has been a recent surge in the application of virus sequences and viral gene expression strategies towards the diagnosis and treatment of diseases.

Results: The scope of the patenting landscape has widened as a result and the current review discusses patents pertaining to live / attenuated viral vaccines. The vaccines addressed here have been developed by both conventional means as well as by the state-of-the-art genetic engineering techniques.

Conclusion: This review also addresses the applications of these patents for clinical and biotechnological purposes.

Keywords: Attenuated virus; adjuvants.; antiviral agents; inactivated viruses; vaccines; virulence factors.

MeSH terms

  • Animal Diseases / therapy*
  • Animals
  • Base Sequence
  • Biotechnology / methods
  • Biotechnology / trends
  • Diabetes Mellitus, Type 1 / therapy*
  • Genetic Engineering / methods
  • Genetic Engineering / trends
  • Humans
  • Patents as Topic*
  • Time Factors
  • Viral Vaccines / genetics
  • Viral Vaccines / therapeutic use*
  • Virology / legislation & jurisprudence*
  • Virology / methods
  • Virology / trends
  • Virus Diseases / therapy*

Substances

  • Viral Vaccines